Indeed, high Smad7 levels, impairing concurrently both TGF-β1 that NF-κB activities, have been found to inhibit damage-mediated inflammation and promote a quickly epithelia self renewal, thus impairing OM development [86]. The gene discussed is NFKB1; the disease is ocular melanoma.